Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT03145467
Eligibility Criteria:
Inclusion Criteria:
* Patients were eligible for inclusion if they were aged 18 years or older, 65 years or younger
* Had acute migraine attack without aura
* VAS (visual analog scale) score \>50 mm , NRS (Numeric Rating Scale) score \>5
* Patients whose written consent is obtained by agreeing to participate in the study
Exclusion Criteria:
* Those who refuse to participate in the work
* Patients younger than 18 years or older than 65 years
* Those who use ergotamine derivative drugs in the last 24 hours
* Have received analgesics in the last 6 hours
* Patients with severe liver, kidney, lung and heart failure
* To have active peptic ulcer bleeding or perforation
* Have a history of upper gastrointestinal disease
* To be Pregnancy and breast-feeding
* Patients of childbearing age who are not using a birth control method.
* Allergy to medicines used in work
* Hemodynamically unstable patients
* Patients with renal transplantation
* Blood pressure uncontrolled hypertension patients
* Patients with cerebrovascular disease history
* Patients with ischemic heart disease or coronary spasm / printzmetal angina
* Patients with arrhythmia accompanying Wolff-Parkinson-White syndrome or accessory conduits in the heart
* Patients with Glucose 6 Phosphate Dehydrogenase (G6PD) deficiency
* Those with other systemic diseases,
* Patients with a Visual Analogue Scale (VAS) pain score less than 50 mm
* Illiterates and patients with vision problems
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03145467
Study Brief:
Protocol Section:
NCT03145467